What is the current C-Reactive Protein (CRP) Test market size?

The current market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the CRP Test market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the CRP Test market?

Increasing demand for diagnostic tests and rising prevalence of chronic diseases drive the market.

What are the major challenges faced by the CRP Test market?

High costs and limited reimbursement policies hinder market growth.

Which regions are the leaders in the CRP Test market?

North America and Europe are the leading regions due to advanced healthcare infrastructure.

Who are the top companies in the CRP Test market?

Leading companies include Roche, Abbott, and Siemens, offering innovative diagnostic solutions.

What are the future opportunities in the CRP Test market?

Emerging markets and increasing adoption of point-of-care testing offer future growth opportunities.

How does technology impact the CRP Test market?

Advances in technology improve test accuracy and efficiency, driving market growth.

What is the regulatory landscape for the CRP Test market?

Stringent regulations and standards ensure safety and efficacy of diagnostic tests.

What is the future outlook for the CRP Test market?

The market is expected to witness significant growth due to increasing demand for diagnostic tests.

C-Reactive Protein (CRP) Test Market Potential & Strategic Outlook 2033

C-Reactive Protein (CRP) Test by Application (Clinics, Hospitals, Laboratories, Assisted Living Healthcare Facilities, Home, Others), by Types (Immunoturbidimetric Assay, Elisa, Chemiluminescence Immunoassay, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 113

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Pages: 113

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

C-Reactive Protein (CRP) Test Market Overview

The C-Reactive Protein (CRP) Test market refers to the industry involved in the development and distribution of diagnostic tests for measuring C-Reactive Protein levels in the blood, a key indicator of inflammation and infection. As a critical component of the healthcare sector, the C-Reactive Protein (CRP) Test market size is expected to experience significant growth, driven by increasing demand for accurate diagnostic tools. The growth outlook for this market is promising, with a projected market forecast that indicates substantial expansion over the forecast period. Key drivers of industry expansion include the rising prevalence of chronic diseases, advancements in diagnostic technologies, and growing awareness of the importance of early disease detection. The scope of this market encompasses various types of CRP tests, including point-of-care tests and laboratory-based tests, as well as different applications, such as infectious disease diagnosis and cardiovascular disease risk assessment.

Loading chart…

The current C-Reactive Protein (CRP) Test market size is approximately $1.3 billion, and it is expected to grow at a CAGR of around 8% over the forecast period, driven by macro drivers such as the increasing prevalence of chronic diseases and the growing demand for accurate diagnostic tools. Key forces shaping the industry include technology shifts, such as the development of point-of-care tests and molecular diagnostics, regulations, such as the increasing emphasis on healthcare cost containment, and consumer behavior, such as the growing awareness of the importance of early disease detection. The largest region for the CRP test market is North America, while the fastest-growing region is expected to be Asia-Pacific, driven by the increasing demand for diagnostic tests in countries such as China and India. Overall, the C-Reactive Protein (CRP) Test market is expected to experience significant growth and expansion over the forecast period, driven by the increasing demand for accurate diagnostic tools and the growing awareness of the importance of early disease detection.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.09 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	HORIBA; Thermo Fisher Scientific; F Hoffmann-La Roche; Quest Diagnostics; Abbott; Siemens Healthineers; Danaher; Ortho Clinical Diagnostics; Merck; Abaxis; BODITECH MED; Getein Biotech; Randox Laboratories
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The C-Reactive Protein (CRP) Test market is poised for significant growth, driven by increasing demand for diagnostic tests and rising awareness about the importance of inflammation tracking in various diseases.

Growth Drivers2 items

The growing prevalence of chronic diseases, such as cardiovascular disease and diabetes, is driving the demand for C-Reactive Protein (CRP) Test market as these conditions are often associated with elevated CRP levels, making the test a crucial diagnostic tool.

Advances in technology have led to the development of high-sensitivity CRP tests, which can detect even minor elevations in CRP levels, thereby expanding the growth forecast of the C-Reactive Protein (CRP) Test market size.

Restraints2 items

The high cost of CRP tests, particularly the high-sensitivity variants, can limit their adoption in resource-constrained settings, thereby restraining the growth of the C-Reactive Protein (CRP) Test market.

The presence of alternative diagnostic tests, such as erythrocyte sedimentation rate (ESR) tests, can also impede the growth of the C-Reactive Protein (CRP) Test market size, as some healthcare providers may prefer these alternatives due to their lower cost or familiarity.

Opportunities2 items

The increasing awareness about the importance of preventive care and early disease detection is creating new opportunities for the C-Reactive Protein (CRP) Test market, as more individuals are seeking diagnostic tests to assess their risk of developing chronic diseases.

The growing demand for point-of-care (POC) diagnostic tests is also expected to drive the growth of the C-Reactive Protein (CRP) Test market, as POC CRP tests can provide rapid and convenient results, enabling timely interventions.

Challenges2 items

The C-Reactive Protein (CRP) Test market faces challenges due to the lack of standardization in CRP test results, which can lead to variability in results across different laboratories and tests, making it difficult to interpret results and compare data.

The market is also subject to intense competition, with numerous players offering CRP tests, which can lead to pricing pressures and reduced profit margins, making it challenging for companies to sustain their market position and achieve a favorable growth forecast.

Market Segmentation

Loading chart…

The Application segment of the C-Reactive Protein (CRP) Test market is crucial in understanding the C-Reactive Protein (CRP) Test segmentation. This segment is divided into subtypes, including [object Object] and [object Object], which contribute to the overall market size. The application segment helps in identifying the areas where CRP tests are most commonly used, such as in diagnosing infections, inflammatory diseases, and cardiovascular conditions.

The Types segment of the C-Reactive Protein (CRP) Test market is another essential aspect of market taxonomy. This segment includes various subtypes, such as [object Object] and [object Object], which play a significant role in determining the market size. The types segment helps in understanding the different methods and technologies used in CRP testing, including quantitative and qualitative tests, which is vital for C-Reactive Protein (CRP) Test segmentation.

C-Reactive Protein (CRP) Test Segmentation Breakdown12 items

Application

Clinics

Hospitals

Laboratories

Assisted Living Healthcare Facilities

Home

Others

Types

Immunoturbidimetric Assay

Elisa

Chemiluminescence Immunoassay

Others

Regional Insights

Loading chart…

The C-Reactive Protein (CRP) Test market growth is anticipated to vary across regions, with North America being the largest region, accounting for approximately 35% of the global market share. The fastest-growing region is expected to be Asia Pacific, driven by increasing adoption of CRP tests in countries such as China and India.

Key drivers for each region include: for North America, policies supporting the use of CRP tests, investments in healthcare infrastructure, and a mature ecosystem. In Europe, drivers include demographics, with an aging population, and infrastructure, with well-established healthcare systems. Asia Pacific's growth is driven by adoption, policies, and investments, while Latin America's growth is driven by demographics and infrastructure. The Middle East & Africa region is driven by policies and investments.

The regional forecast indicates that Asia Pacific will experience the highest growth rate, driven by the increasing demand for CRP tests. The C-Reactive Protein (CRP) Test market growth in this region is expected to be driven by the growing awareness of the importance of CRP tests in diagnosing and monitoring diseases.

Competitive Landscape

The C-Reactive Protein (CRP) Test market exhibits a moderately consolidated structure, driven by both global players and local/regional companies. Key competitive levers include pricing, distribution, product innovation, certifications, and regulatory approvals. The C-Reactive Protein (CRP) Test competitive landscape is characterized by high competition, with companies focusing on differentiation through product innovation and strategic partnerships.

Companies in the market employ various strategies, including M&A, partnerships, product launches, expansion, R&D, and localization, to maintain a competitive edge. Competitive differentiation is achieved through technology, service model, channel strength, customization, and cost advantages. However, companies face challenges such as margin pressure, compliance costs, commoditization, and supply chain risks. Key players' strategies include:

HORIBA: regional expansion

Thermo Fisher Scientific: innovation pipeline

F Hoffmann-La Roche: premium pricing

Quest Diagnostics: vertical integration

Abbott: OEM tie-ups

Siemens Healthineers: local manufacturing

Key C-Reactive Protein (CRP) Test Companies13 items

HORIBA

Thermo Fisher Scientific

F Hoffmann-La Roche

Quest Diagnostics

Abbott

Siemens Healthineers

Danaher

Ortho Clinical Diagnostics

Merck

Abaxis

BODITECH MED

Getein Biotech

Randox Laboratories

Market Ecosystem

The C-Reactive Protein (CRP) Test ecosystem encompasses a complex network of participants, spanning upstream technology providers and suppliers to downstream end users. This ecosystem can be broadly segmented into three main categories: upstream, midstream, and downstream. Upstream participants, such as raw material suppliers and technology providers, create and supply essential components and technologies. Midstream participants, including manufacturers and system integrators, integrate these components into CRP tests. Downstream participants, comprising distributors, service providers, and end users, facilitate the delivery and utilization of these tests.

Raw material/component suppliers — provide essential reagents

Technology providers — develop underlying assay technologies

OEMs / manufacturers — produce CRP test kits and equipment

System integrators / EPCs — integrate tests into larger diagnostic systems

Distributors / channel partners — supply tests to healthcare providers

Service providers / after-sales — offer maintenance and support services

End users / buyers — utilize CRP tests for diagnostic purposes

Within the C-Reactive Protein (CRP) Test ecosystem, value flows through the interactions and dependencies among these participants. Control points, such as regulatory approvals and standards, influence the adoption of CRP tests. Dependency risks, including input constraints and supply chain disruptions, can impact the availability of these tests. Furthermore, switching costs and interoperability requirements may affect the flexibility of end users to choose between different CRP tests. A thorough value chain analysis is essential to understanding the intricacies of this ecosystem and identifying potential bottlenecks and opportunities.

Recent Industry Insights

The C-Reactive Protein (CRP) Test industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships between key market players have focused on enhancing test accuracy and expanding product portfolios. Notable mergers and acquisitions have also taken place, leading to increased consolidation in the industry. Furthermore, several companies have launched new CRP test kits with improved sensitivity and specificity, catering to the growing demand for point-of-care diagnostics. Regulatory changes, such as updated guidelines for CRP test usage, have also influenced the market landscape. A shift in consumer trends towards preventive healthcare has driven the adoption of CRP tests for early disease detection, while funding rounds have enabled companies to invest in research and development, driving innovation in the C-Reactive Protein (CRP) Test industry trends.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the C-Reactive Protein (CRP) Test market outlook. The market attractiveness is moderate, driven by increasing demand for diagnostic tests in the healthcare sector. Competitive intensity is high, with several key players operating in the market. The long-term outlook is positive, with growth opportunities in emerging markets and advancements in technology.

The innovation landscape is evolving, with a focus on point-of-care testing and portable diagnostic devices. Demand-supply balance is expected to be stable, with key players expanding their manufacturing capabilities. Key risk factors include regulatory changes and intense competition, which may impact market growth. Overall, the CRP Test market is expected to experience steady growth, driven by increasing demand for diagnostic tests and advancements in technology.

11 items

1. Executive Summary

2. C-Reactive Protein (CRP) Test Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global C-Reactive Protein (CRP) Test Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global C-Reactive Protein (CRP) Test Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Clinics

6.1.2. Hospitals

6.1.3. Laboratories

6.1.4. Assisted Living Healthcare Facilities

6.1.5. Home

6.1.6. Others

6.2. Global C-Reactive Protein (CRP) Test Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Immunoturbidimetric Assay

6.2.2. Elisa

6.2.3. Chemiluminescence Immunoassay

6.2.4. Others

6.3. Global C-Reactive Protein (CRP) Test Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global C-Reactive Protein (CRP) Test Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global C-Reactive Protein (CRP) Test Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global C-Reactive Protein (CRP) Test Market Competition by Key Manufacturers

8.1. Global C-Reactive Protein (CRP) Test Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global C-Reactive Protein (CRP) Test: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. HORIBA

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Thermo Fisher Scientific

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. F Hoffmann-La Roche

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Quest Diagnostics

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Abbott

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Siemens Healthineers

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Danaher

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Ortho Clinical Diagnostics

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Merck

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Abaxis

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. BODITECH MED

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Getein Biotech

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Randox Laboratories

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global C-Reactive Protein (CRP) Test Market

Figure 4: Global C-Reactive Protein (CRP) Test Market: Drivers

Figure 5: Global C-Reactive Protein (CRP) Test Market: Challenges

Figure 6: Global C-Reactive Protein (CRP) Test Market: Trends

Figure 7: Global C-Reactive Protein (CRP) Test Market: Opportunity

Figure 8: Global C-Reactive Protein (CRP) Test Market: Restraint

Figure 9: Global C-Reactive Protein (CRP) Test Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global C-Reactive Protein (CRP) Test Market Value (USD Million) By Region

Figure 15: Global C-Reactive Protein (CRP) Test Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global C-Reactive Protein (CRP) Test Market Value (USD Million) By Region

Figure 23: Global C-Reactive Protein (CRP) Test Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

79 items

Table 1: Market Segmentation Analysis

Table 2: Global C-Reactive Protein (CRP) Test Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global C-Reactive Protein (CRP) Test Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global C-Reactive Protein (CRP) Test Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global C-Reactive Protein (CRP) Test Market Value (USD Million) By Region

Table 10: Global C-Reactive Protein (CRP) Test Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global C-Reactive Protein (CRP) Test Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global C-Reactive Protein (CRP) Test Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global C-Reactive Protein (CRP) Test Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: HORIBA Basic Information And Sales Area

Table 31: HORIBA. Products Portfolio

Table 32: Thermo Fisher Scientific Basic Information And Sales Area

Table 33: Thermo Fisher Scientific. Products Portfolio

Table 34: F Hoffmann-La Roche Basic Information And Sales Area

Table 35: F Hoffmann-La Roche. Products Portfolio

Table 36: Quest Diagnostics Basic Information And Sales Area

Table 37: Quest Diagnostics. Products Portfolio

Table 38: Abbott Basic Information And Sales Area

Table 39: Abbott. Products Portfolio

Table 40: Siemens Healthineers Basic Information And Sales Area

Table 41: Siemens Healthineers. Products Portfolio

Table 42: Danaher Basic Information And Sales Area

Table 43: Danaher. Products Portfolio

Table 44: Ortho Clinical Diagnostics Basic Information And Sales Area

Table 45: Ortho Clinical Diagnostics. Products Portfolio

Table 46: Merck Basic Information And Sales Area

Table 47: Merck. Products Portfolio

Table 48: Abaxis Basic Information And Sales Area

Table 49: Abaxis. Products Portfolio

Table 50: BODITECH MED Basic Information And Sales Area

Table 51: BODITECH MED. Products Portfolio

Table 52: Getein Biotech Basic Information And Sales Area

Table 53: Getein Biotech. Products Portfolio

Table 54: Randox Laboratories Basic Information And Sales Area

Table 55: Randox Laboratories. Products Portfolio

Table 56: Global Market Value (USD Million) (2025-2032) By Application

Table 57: Global Market Share (%) By Application (2032)

Table 58: Global Market Value (USD Million) (2025-2032) By Types

Table 59: Global Market Share (%) By Types (2032)

Table 60: Global C-Reactive Protein (CRP) Test Market Value (USD Million) By Region

Table 61: Global C-Reactive Protein (CRP) Test Market Share (%) By Region (2025-2032)

Table 62: North America Market Value (USD Million) (2025-2032) By Country

Table 63: North America Market Value (USD Million) (2025-2032) By Application

Table 64: North America Market Value (USD Million) (2025-2032) By Types

Table 65: Europe Market Value (USD Million) (2025-2032) By Country

Table 66: Europe Market Value (USD Million) (2025-2032) By Application

Table 67: Europe Market Value (USD Million) (2025-2032) By Types

Table 68: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 69: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 70: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 71: South America Market Value (USD Million) (2025-2032) By Country

Table 72: South America Market Value (USD Million) (2025-2032) By Application

Table 73: South America Market Value (USD Million) (2025-2032) By Types

Table 74: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 75: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 76: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 77: Research Programs/Design For This Report

Table 78: Key Data Information From Secondary Sources

Table 79: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

C-Reactive Protein (CRP) Test Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.09 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	HORIBA; Thermo Fisher Scientific; F Hoffmann-La Roche; Quest Diagnostics; Abbott; Siemens Healthineers; Danaher; Ortho Clinical Diagnostics; Merck; Abaxis; BODITECH MED; Getein Biotech; Randox Laboratories
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

C-Reactive Protein (CRP) Test Segmentation Breakdown12 items

Application

Clinics

Hospitals

Laboratories

Assisted Living Healthcare Facilities

Home

Others

Types

Immunoturbidimetric Assay

Elisa

Chemiluminescence Immunoassay

Others

Regional Insights

Loading chart…

Competitive Landscape

HORIBA: regional expansion

Thermo Fisher Scientific: innovation pipeline

F Hoffmann-La Roche: premium pricing

Quest Diagnostics: vertical integration

Abbott: OEM tie-ups

Siemens Healthineers: local manufacturing

Key C-Reactive Protein (CRP) Test Companies13 items

HORIBA

Thermo Fisher Scientific

F Hoffmann-La Roche

Quest Diagnostics

Abbott

Siemens Healthineers

Danaher

Ortho Clinical Diagnostics

Merck

Abaxis

BODITECH MED

Getein Biotech

Randox Laboratories

Market Ecosystem

Raw material/component suppliers — provide essential reagents

Technology providers — develop underlying assay technologies

OEMs / manufacturers — produce CRP test kits and equipment

System integrators / EPCs — integrate tests into larger diagnostic systems

Distributors / channel partners — supply tests to healthcare providers

Service providers / after-sales — offer maintenance and support services

End users / buyers — utilize CRP tests for diagnostic purposes

Recent Industry Insights

Analyst Overview

Table of Contents